- Home
- AIRT vs JSPR Comparison
AIRT vs JSPR Comparison
Compare AIRT & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRT
- JSPR
- Stock Information
- Founded
- AIRT 1980
- JSPR 2018
- Country
- AIRT United States
- JSPR United States
- Employees
- AIRT N/A
- JSPR N/A
- Industry
- AIRT Air Freight/Delivery Services
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AIRT Consumer Discretionary
- JSPR Health Care
- Exchange
- AIRT Nasdaq
- JSPR Nasdaq
- Market Cap
- AIRT 61.2M
- JSPR 68.4M
- IPO Year
- AIRT N/A
- JSPR N/A
- Fundamental
- Price
- AIRT $18.35
- JSPR $1.79
- Analyst Decision
- AIRT
- JSPR Buy
- Analyst Count
- AIRT 0
- JSPR 12
- Target Price
- AIRT N/A
- JSPR $25.60
- AVG Volume (30 Days)
- AIRT 1.4K
- JSPR 431.6K
- Earning Date
- AIRT 11-12-2025
- JSPR 11-10-2025
- Dividend Yield
- AIRT N/A
- JSPR N/A
- EPS Growth
- AIRT N/A
- JSPR N/A
- EPS
- AIRT N/A
- JSPR N/A
- Revenue
- AIRT $279,216,000.00
- JSPR N/A
- Revenue This Year
- AIRT N/A
- JSPR N/A
- Revenue Next Year
- AIRT N/A
- JSPR N/A
- P/E Ratio
- AIRT N/A
- JSPR N/A
- Revenue Growth
- AIRT N/A
- JSPR N/A
- 52 Week Low
- AIRT $14.56
- JSPR $1.56
- 52 Week High
- AIRT $26.70
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- AIRT 26.31
- JSPR 38.62
- Support Level
- AIRT $20.93
- JSPR $1.56
- Resistance Level
- AIRT $21.00
- JSPR $1.92
- Average True Range (ATR)
- AIRT 0.34
- JSPR 0.18
- MACD
- AIRT -0.36
- JSPR 0.01
- Stochastic Oscillator
- AIRT 0.00
- JSPR 30.52
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.